Harrow reports Q3 core EPS 33c, consensus 29c

Reports Q3 revenue $71.64M, consensus $73.7M. “The third quarter represented another period of meaningful progress for Harrow (HROW). We continued to execute across our portfolio, driving strong performance from VEVYE and IHEEZO, while advancing several strategic initiatives that strengthen our foundation for future growth,” said Mark L. Baum, Chief Executive Officer of Harrow. “With the launch of TRIESENCE into its largest market opportunity, the upcoming rollout of our Harrow Access for All program, the expansion of our commercial leadership team, and new major coverage wins for VEVYE, we are well-positioned for a terrific close to the year and sustained growth for many years to come.